| Page 106 | Kisaco Research

Machine learning is reshaping discovery science in Human Health and Organicin Scientific is proving its potential in animal health too. Mat Mitchell, Co-Founder and CTO, shares how Organicin Scientific’s machine-learning platform automates candidate selection to identify, evaluate, and commercialise novel antimicrobials for safe and sustainable use across the industry.

Machine Learning
R&D
Drug Discovery
Antimicrobial
AI

Author:

Mathew Mitchell

Co-Founder and CTO
Organicin Scientific

Mathew Mitchell

Co-Founder and CTO
Organicin Scientific

With resistance to existing parasiticides rising and few new molecules in decades, ASTRA Therapeutics set out to change the game. Co-CEOs Natacha Gaillard and Ashwani Sharma share how the company closed one of the largest seed rounds in animal health, positioned itself to deliver precision-designed antiparasitics, and built investor confidence in solving one of animal health’s most urgent challenges.

Milestone - Funding
Parasiticides
Investment
Seed Funding
Biopharma
Companion and Livestock

Author:

Natacha Gaillard

Co-Founder and Co-CEO
ASTRA Therapeutics

Natacha Gaillard

Co-Founder and Co-CEO
ASTRA Therapeutics

Author:

Ashwani Sharma

Co-Founder and Co-CEO
ASTRA Therapeutics

Ashwani Sharma

Co-Founder and Co-CEO
ASTRA Therapeutics
 

Niamh Gallagher

Program Director - AHNTI
Kisaco Research

Niamh Gallagher

Program Director - AHNTI
Kisaco Research

Niamh Gallagher

Program Director - AHNTI
Kisaco Research
 

Niamh Gallagher

Program Director - AHNTI
Kisaco Research

Niamh Gallagher

Program Director - AHNTI
Kisaco Research

Niamh Gallagher

Program Director - AHNTI
Kisaco Research
 

Jim McIntyre

Head of Global Business Development
Merck Animal Health

Jim McIntyre

Head of Global Business Development
Merck Animal Health

Jim McIntyre

Head of Global Business Development
Merck Animal Health